Cargando…

Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study

OBJECTIVE: The authors aimed to evaluate psychometric properties of the Concise Associated Symptom Tracking (CAST) Scale and validate the clinical utility of measuring irritability by updating and replicating a previously published outcome calculator from the Combining Medications to Enhance Depress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minhajuddin, Abu, Jha, Manish K., Fatt, Cherise Chin, Trivedi, Madhukar H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175787/ https://www.ncbi.nlm.nih.gov/pubmed/36101888 http://dx.doi.org/10.1176/appi.prcp.20190041

Ejemplares similares

Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale
por: Jha, Manish K, et al.
Publicado: (2017)

Brain Ventricle and Choroid Plexus Morphology as Predictor of Treatment Response: Findings from the EMBARC Study
por: Murck, Harald, et al.
Publicado: (2023)

Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
por: Jha, Manish K., et al.
Publicado: (2019)

Immune characterization of suicidal behavior in female adolescents
por: Chin Fatt, Cherise R., et al.
Publicado: (2022)

Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial
por: Cooper, Crystal M., et al.
Publicado: (2019)

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study
por: Chin Fatt, Cherise R., et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on adults with current and prior depression: initial findings from the longitudinal Texas RAD study
por: Czysz, Andrew H., et al.
Publicado: (2021)

Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial
por: Giles, Michael A., et al.
Publicado: (2023)

Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
por: Jha, Manish K, et al.
Publicado: (2019)

Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
por: Jha, Manish K, et al.
Publicado: (2017)

Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study
por: Petkova, Eva, et al.
Publicado: (2017)

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients
por: Jha, Manish K., et al.
Publicado: (2016)

The EMBARC European Bronchiectasis Registry: protocol for an international observational study
por: Chalmers, James D., et al.
Publicado: (2016)

Patient participation in ERS guidelines and research projects: the EMBARC experience
por: Chalmers, James D., et al.
Publicado: (2017)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha, Manish K, et al.
Publicado: (2017)

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
por: Jha, Manish K., et al.
Publicado: (2018)

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory
por: Mason, Brittany L., et al.
Publicado: (2022)

Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration
por: Shteinberg, Michal, et al.
Publicado: (2019)

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
por: Shteinberg, Michal, et al.
Publicado: (2021)

Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry
por: Dhar, Raja, et al.
Publicado: (2023)

ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group
por: Traversi, Letizia, et al.
Publicado: (2021)

Accounting for Dynamic Fluctuations across Time when Examining fMRI Test-Retest Reliability: Analysis of a Reward Paradigm in the EMBARC Study
por: Chase, Henry W., et al.
Publicado: (2015)

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients
por: Nandy, Karabi, et al.
Publicado: (2022)

Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR(16)) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial
por: Trombello, Joseph M, et al.
Publicado: (2023)

The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR(9)) measure of suicidal risk: Performance in adult primary care patients
por: Nandy, Karabi, et al.
Publicado: (2023)

Brain Regulation of Emotional Conflict Predicts Antidepressant Treatment Response for Depression
por: Fonzo, Gregory A., et al.
Publicado: (2019)

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
por: Chalmers, James D., et al.
Publicado: (2017)

Validation and psychometric evaluation of the Swedish version of the Nasal Obstruction Symptom Evaluation scale
por: Sunnergren, Ola, et al.
Publicado: (2023)

Validation of the Concise Assessment Scale for Children’s Handwriting (BHK) in an Italian Population
por: Loizzo, Annalivia, et al.
Publicado: (2023)

The concise measurement of clinical communication skills: Validation of a short scale
por: Maaß, Ulrike, et al.
Publicado: (2022)

Validation and Psychometric Properties of the Tobacco Urge Management Scale (TUMS)
por: Chin, Samantha M., et al.
Publicado: (2023)

The Development and Psychometric Validation of an Arabic-Language Version of the Pain Catastrophizing Scale
por: Huijer, Huda Abu-Saad, et al.
Publicado: (2017)

The Turkish COVID-19 Anxiety Syndrome Scale: Psychometric validation and association with psychological symptoms
por: Obuca, F., et al.
Publicado: (2023)

Psychometric and Clinical Evaluation of the Clinician (VQIDS-C(5)) and Self-Report (VQIDS-SR(5)) Versions of the Very Quick Inventory of Depressive Symptoms
por: Rush, A John, et al.
Publicado: (2022)

Patient-Centered Communication (PCC) scale: Psychometric analysis and validation of a health survey measure
por: Moser, Richard P., et al.
Publicado: (2022)

Psychometric validation of the Cardiac Rehabilitation Barriers Scale
por: Shanmugasegaram, Shamila, et al.
Publicado: (2012)

Development and Psychometric Validation of the Dementia Attitudes Scale
por: O'Connor, Melissa L., et al.
Publicado: (2010)

Development and Psychometric Validation of the Music Receptivity Scale
por: George, Mahesh, et al.
Publicado: (2021)

A New Questionnaire to Assess Respiratory Symptoms (The Respiratory Symptom Experience Scale): Quantitative Psychometric Assessment and Validation Study
por: Shiffman, Saul, et al.
Publicado: (2023)

Psychometric properties of the Vertigo symptom scale – Short form
por: Wilhelmsen, Kjersti, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ec79fhq7u90bcpoo6phudj1ho5